4.6 Article

TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase

Journal

JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 281, Issue 13, Pages 8313-8316

Publisher

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.C500451200

Keywords

-

Funding

  1. NIA NIH HHS [T32 AG00114-18] Funding Source: Medline
  2. NIDDK NIH HHS [R01 DK124709] Funding Source: Medline

Ask authors/readers for more resources

Tuberous sclerosis complex ( TSC) is an autosomal dominant disease characterized by hamartoma formation in various organs. Two genes responsible for the disease, TSC1 and TSC2, have been identified. The TSC1 and TSC2 proteins, also called hamartin and tuberin, respectively, have been shown to regulate cell growth through inhibition of the mammalian target of rapamycin pathway. TSC1 is known to stabilize TSC2 by forming a complex with TSC2, which is a GTPase- activating protein for the Rheb small GTPase. We have identified HERC1 as a TSC2- interacting protein. HERC1 is a 532- kDa protein with an E3 ubiquitin ligase homology to E6AP carboxyl terminus ( HECT) domain. We observed that the interaction of TSC1 with TSC2 appears to exclude TSC2 from interacting with HERC1. Disease mutations in TSC2, which result in its destabilization, allow binding to HERC1 in the presence of TSC1. Our study reveals a potential molecular mechanism of how TSC1 stabilizes TSC2 by excluding the HERC1 ubiquitin ligase from the TSC2 complex. Furthermore, these data reveal a possible biochemical basis of how certain disease mutations inactivate TSC2.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available